Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0552
E

Failure to Provide and Document Complete Psychotropic Medication Information

Louisburg, Kansas Survey Completed on 08-26-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to adequately inform several residents and/or their representatives about the specific risks, benefits, and alternatives associated with their prescribed psychotropic medications. In multiple cases, the consent forms provided to residents only listed the general class of medication (such as antidepressant, antipsychotic, or antianxiety) and potential side effects for the class, but did not include the names of the individual medications, their prescribed dosages, or the specific reasons for their use. This lack of detailed information was observed in the records of residents with varying degrees of cognitive function, including those with intact cognition and those with moderate to severe cognitive impairment. For example, one resident with diagnoses including altered mental status, metabolic encephalopathy, and anxiety disorder had a consent form that omitted the names and dosages of prescribed medications such as Buspar and Cymbalta. Another resident with borderline personality disorder, cerebral palsy, and major depressive disorder was prescribed multiple psychotropic medications, but the consent form again lacked specific medication names and dosages. In both cases, administrative staff confirmed that while residents were verbally informed about their medications, this education was not documented in the medical record as required by facility policy. Additional residents with diagnoses such as schizophrenia, alcohol-induced dementia, and depression were also found to have incomplete psychotropic consent documentation. In some instances, residents expressed confusion or dissatisfaction regarding their medications, with one resident stating they were told an antidepressant would help with pain, but it was not effective. The facility's policy required that residents and/or their representatives be informed and that this communication be documented, but this was not consistently done, leading to the deficiency.

An unhandled error has occurred. Reload 🗙